These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15988337)

  • 21. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis.
    Hoshii Y; Takahashi M; Ishihara T; Uchino F
    Pathol Int; 1994 May; 44(5):352-8. PubMed ID: 8044304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues.
    Shtrasburg S; Pras M; Langevitch P; Gal R
    Am J Pathol; 1982 Feb; 106(2):141-4. PubMed ID: 7065112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms.
    Chopra S; Rubinow A; Koff RS; Cohen AS
    Am J Pathol; 1984 May; 115(2):186-93. PubMed ID: 6202147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases.
    Yıldırım T; Kütahya B; İş F; Erdevir M; Üzerk Kibar M; Koç NS; Ayhan EA; Yılmaz ŞR; Erdem Y
    Turk J Med Sci; 2021 Oct; 51(5):2364-2368. PubMed ID: 33984890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac amyloidosis revealing multiple myeloma].
    Denguir H; Ben-Hamda K; Gharbi M; Addad F; Hammami S; Mlika A; Abbes F; Moussa A; Betbout F; Gamra H; Maatouk F; Dridi Z; Zakhama A; Mahjoub S; Ben-Farhat M
    Tunis Med; 2005 May; 83(5):300-4. PubMed ID: 16044906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of amyloid lymphadenopathy in uremic patients.
    Güz G; Ozdemir BH; Sezer S; Yakupoglu U; Demirhan B; Ozdemir FN; Haberal M
    Ren Fail; 2000; 22(5):613-21. PubMed ID: 11041293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
    Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis.
    Sarsik B; Sen S; Kirdok FS; Akarca US; Toz H; Yilmaz F
    Pathol Res Pract; 2012 Dec; 208(12):713-8. PubMed ID: 23154038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis.
    Blank N; Hegenbart U; Dietrich S; Brune M; Beimler J; Röcken C; Müller-Tidow C; Lorenz HM; Schönland SO
    Amyloid; 2018 Mar; 25(1):37-45. PubMed ID: 29364741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
    Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
    Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.